COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies

Rheumatology (Oxford). 2023 Jun 1;62(6):e175-e179. doi: 10.1093/rheumatology/keac644.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Female
  • Humans
  • Myositis* / chemically induced
  • Pregnancy

Substances

  • COVID-19 Vaccines